Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:10 PM
Ignite Modification Date:
2025-12-24 @ 10:10 PM
NCT ID:
NCT03918135
Eligibility Criteria:
Inclusion Criteria:
* Patients who have fever for less than five days
* At least 1 upper respiratory tract infection (URTI) symptom according URTI questionare
Exclusion Criteria:
* Patients use anti-pyretic last 4 hours
* To be Pregnancy and breast-feeding Patients of childbearing age who are not using a birth control method
* Patients with an allergy trait (paracetamol and Ibuprofen) Illiterates
* Hemodynamically unstable patients
* Patients with renal transplantation
* Patients with glucose 6 phosphate dehydrogenase (G6PD) deficiency
* Patients with non-controlled hypertension
* Patients with a history of cerebrovascular disease
* Patients with severe liver, kidney,pulmonary and cardiac heart failure
* Patients use antibiotics last 7 days
* Patients with Wolff-Parkinson-White syndrome or accompanying arrhythmias associated with conductive stimulus delivery in the heart
* Patients with vision problems
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03918135
Study Brief:
Protocol Section:
NCT03918135